Gottenberg et al. A positive RCT in pSS! DAHLIAS study. Phase 2. 163 patients. Nipocalimab, anti-neonatal Fc receptor (FcRn) mAb. @RheumNow #ACR24 Abstr#2527 https://t.co/M7li4ZoKeY https://t.co/gV9MGnswdR
Links:
Efficacy and Safety of Nipocalimab, an Anti-FcRn Monoclonal Antibody, in Primar…
https://acrabstracts.org/abstract/efficacy-and-safety-of-nipocalimab-an-anti-fc…
18-11-2024